7.295
price down icon7.42%   -0.585
after-market Handel nachbörslich: 7.30 0.005 +0.07%
loading

Finanzdaten der Adverum Biotechnologies Inc-Aktie (ADVM)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - 3.60
Operating Expenses
2.60%
26.84
26.16 34.53 33.06 33.84
Depreciation and Amortization
1.19%
0.997
1.009 1.509 1.534 1.592
Operating Income/Loss
2.60%
-26.84
-26.16 -34.53 -33.06 -30.24
Nonoperating Income/Loss
56.52%
2.052
1.311 1.661 1.576 1.20
Income/Loss From Continuing Operations Before Tax
0.24%
-24.79
-24.85 -32.87 -31.49 -29.04
Income Tax Expense/Benefit
100.00%
-
-1.133 0.017 0.021 0.017
Income/Loss From Continuing Operations After Tax
4.52%
-24.79
-23.71 -32.88 -31.51 -29.06
Net Income/Loss
4.52%
-24.79
-23.71 -32.88 -31.51 -29.06
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
12,479%
16.48
0.131 101.00 100.77 100.30
Diluted Average Shares
12,479%
16.48
0.131 101.00 100.77 100.30
Basic Earnings Per Share
552.17%
-1.50
-0.23 -0.33 -0.31 -0.29
Diluted Earnings Per Share
552.17%
-1.50
-0.23 -0.33 -0.31 -0.29
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$22.32
price down icon 1.11%
$74.12
price up icon 0.26%
$373.97
price up icon 3.48%
$54.36
price down icon 0.66%
$202.64
price down icon 1.63%
$113.10
price down icon 0.74%
Kapitalisierung:     |  Volumen (24h):